Possible tumor development from double positive foci for TGF-alpha and GST-P observed in early stages on rat hepatocarcinogenesis

Cancer Science

Volumn 97, Issue 6, 2006, Pages 478-483

  Kitano, Mitsuaki ^a,b   Wada, Jutaro ^b   Ariki, Yutaka ^b   Kato, Masanori ^b   Wanibuchi, Hideki ^a   Morimura, Keiichirou ^a   Hidaka, Takayoshi ^b   Hosoe, Kazunori ^b   Fukushima, Shoji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANEKA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTATHIONE TRANSFERASE; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER GROWTH; CANCER INCIDENCE; CONTROLLED STUDY; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LIVER CARCINOGENESIS; LIVER RESECTION; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; DIETHYLNITROSAMINE; GLUTATHIONE S-TRANSFERASE PI; HEPATECTOMY; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PHENOBARBITAL; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 33744550042     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00210.x     Document Type: Article

References (29)

1. Ito N, Tamano S, Shirai T. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci 2003; 94: 3-8.
2. Ito N, Tsuda H, Tatematsu M et al. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats - an approach for a new medium-term bioassay system. Carcinogenesis 1988; 9: 387-94.
3. Ito N, Hasegawa R, Imaida K et al. Medium-term rat liver bioassay for rapid detection of hepatocarcinogenic substances. J Toxicol Pathol 1997; 10: 1-11.
4. International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use. Testing for Carcinogenic Activity 1995.
5. Sato K, Kitahara A, Satoh K, Ichikawa T, Tatematsu M, Ito N. The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical carcinogenesis. Gann 1984; 75: 199-202.
6. Tatematsu M, Mera Y, Ito N, Satoh K, Sato K. Relative merits of immunohistochemical demonstration of placental A, B and C forms of glutathione S-transferase and histochemical demonstration of γ-glutamyl transferase as marker of altered foci during liver carcinogenesis in rats. Carcinogenesis 1985; 6: 1621-6.
7. Ogiso T, Tatematsu M, Tamano S, Hasegawa R, Ito N. Correlation between medium-term liver bioassay system data and results of long-term testing in rats. Carcinogenesis 1990; 11: 561-6.
8. Kitano M, Ichihara T, Matsuda T et al. Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat. Carcinogenesis 1998; 19: 1475-80.
9. Kitano M, Ariki Y, Wada J et al. Lack of inhibitory effects of coumaperine from pepper on the promotion stage of chemical hepatocarcinogenesis in the rat. J Toxicol Pathol 2003; 16: 161-4.
10. Ignotz RA, Kelly B, Davis RJ, Massague J. Biologically active precursor for transforming growth factor type α, released by retrovirally transformed cells. Proc Natl Acad Sci USA 1986; 83: 6307-11.
11. Pandiella A, Massague J. Transforming growth factor-alpha. Biochem Soc Trans 1991; 19: 259-62.
12. Tamano S, Merlino GT, Ward JM. Rapid development of hepatic tumors in transforming growth factor α transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital. Carcinogenesis 1994; 15: 1791-8.
13. Hsia CC, Axiotis CA, DiBisceglie AM, Tabor E. Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver. Cancer 1992; 70: 1049-56.
14. Burr AW, Toole B, Mathew J, Hines JE, Chapman C, Burt AD. Transforming growth factor-α expression in altered foci during experimental hepatocarcinogenesis. J Pathol 1996; 179: 276-82.
15. Moser GJ, Wolf DC, Goldsworthy TL. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver. Toxicol Pathol 1997; 25: 275-83.
16. Peraino C, Michael RJ, Staffeldt E. Enhancement of spontaneous hepatic tumorigenesis in C3H mice by dietary phenobarbital. J Natl Cancer Inst 1973; 51: 1349-50.
17. Feldman D, Swarm RL, Becker J. Ultrastructural study of rat liver neoplasms after long-term treatment with phenobarbital. Cancer Res 1981; 41: 2151-62.
18. Sander S, Thorgeirsson SS. Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice. Mol Cacinog 2000; 28: 168-73.
19. Japanese Association for Laboratory Animal Science. Guideline for animal experimentation. Exp Anim 1987; 36: 285-8.
20. Hsu SM, Raine L, Fanger H. Use of avidine-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80.
21. Watanabe T, Katsura Y, Yoshitake A. IPAP: Image processor for analytical pathology. J Toxicol Pathol 1994; 7: 353-61.
22. Kaufmann WK, Zhang Y, Kaufmann DG. Association between expression of transforming growth factor-alpha and progression of hepatocellular foci to neoplasms. Carcinogenesis 1992; 13: 1481-3.
23. Tanno S, Ogawa K. Abundant TGF-α precursor and EGF receptor expression as a possible mechanism for the preferential growth of carcinogen-induced preneoplastic and neoplastic hepatocytes in rats. Carcinogenesis 1994; 15: 1689-94.
24. Hagiwara A, Miyata E, Tamano S et al. Non-carcinogenicity, but dose related increase in preneoplastic hepatocellular lesions, in a two-year feeding study of phenobarbital sodium in male F344 rats. Food Chem Toxicol 1999; 37: 869-79.
25. Masuda C, Wanibuchi H, Otori K et al. Presence of a no-observed effect level for enhancing effects of the α-isomer of benzene hexachloride (α-BHC) on development of diethylnitrosamine-initiated hepatic foci in rats. Cancer Lett 2001; 163: 179-85.
26. Hasegawa R, Shirai T, Hakoi K et al. Synergistic enhancement of glutathione S-transferase placental form-positive hepatic foci development in diethylnitrosamine-treated rats by combined administration of five heterocyclic amines at low doses. Jpn J Cancer Res 1991; 82: 1378-84.
27. Yamada Y, Yoshimi N, Sugie S et al. β-catenin (Ctnnb1) gene mutation in diethylnitrosamine (DEN)-induced liver tumors in male F344 rats. Jpn J Cancer Res 1999; 90: 824-828.
28. Tsujiuchi T, Tsutsumi M, Sasaki Y, Takahama M, Konishi Y. Different frequencies and patterns of β-catenin mutation in hepatocellular carcinomas induced by N-nitrosodiethylamine and a choline-deficient L-amino acid-defined diet in rats. Cancer Res 1999; 59: 3904-3907.
29. Kawamori T, Totsuka Y, Uchiya N et al. Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats. Carcinogenesis 2004; 25: 1967-72.